CAMPBELL, Calif.–(BUSINESS WIRE)–May 5, 2020–
Saama Technologies, Inc. (“Saama”), the #1 AI scientific analytics platform firm, and iNDX.Ai, a number one Multi-omics Data Analytics and translational analysis platform firm, at the moment introduced the launch of the brand new COVID-19 Command Center. The COVID-19 Command Center, primarily based on a mix of Saama’s Life Science Analytics Cloud (LSAC) and iNDX.Ai’s iCore Platform, is a purpose-built, therapeutic area-specific knowledge analytics platform that may speed up the flexibility of life sciences firms to expedite inner analysis and improvement packages for therapies to forestall and deal with COVID-19.
Many biopharma organizations are sharing COVID-19 analysis knowledge by organizations such because the just lately established EndPandemic National Data Consortium, which six firms – together with Saama and iNDX.Ai – have joined. The COVID-19 Command Center was created to offer sponsors pursuing in-house COVID-19 scientific improvement efforts solely with the identical highly effective, state-of-the-art, AI-powered knowledge analytics platform being utilized by the EndPandemic National Data Consortium. The COVID-19 Command Center contains affected person knowledge from ongoing COVID-19 scientific trials in China, South Korea, and the U.S. with practically 8,500 sufferers, together with over 3,000 optimistic circumstances. The COVID-19 Command Center delivers all of the multiomics and scientific knowledge analytics wanted to handle COVID-19 scientific research. From preclinical improvement to approval, researchers can optimize examine design, affected person choice, website activation and scientific evaluation by dynamically visualizing, analyzing, and interrogating knowledge quicker than ever earlier than.
“Saama wants all life science companies, whether they are engaged in public or private research efforts, to have access to the best possible analytics platform so they can expedite promising COVID-19 clinical trials and bring critical vaccines and treatments to the market as soon as possible,” mentioned Suresh Katta, Founder and CEO of Saama Technologies. “The COVID-19 Command Center, the first offering from Saama’s purpose-built Command Center strategy, is customized to meet immediate needs related to research on the novel coronavirus, but can also be used more broadly for other infectious disease clinical development efforts now and in the future.”
“iNDX.Ai believes that AI-enabled, multi-modal deep and dense data analytics will help biopharma companies accelerate their translational research in clinical trials to deliver therapies that could potentially treat and prevent COVID-19,” mentioned Mohan Uttarwar, CEO of iNDX.Ai. “The COVID-19 Command Center ensures that every life science company, whether engaged in solo or collaborative research, will be able to apply state-of-the-art data analytics to inform and advance their research and help end the pandemic. By partnering on the COVID-19 Command Center, iNDX.Ai and Saama provide an end-to-end clinical development solution, from in silico biomarker discovery to Investigational New Drug (IND) application submission.”
Learn extra about utilizing the purpose-built COVID-19 Command Center to optimize COVID-19 scientific analysis.
Life Science Analytics Cloud (LSAC) is the main AI-powered scientific analytics platform that seamlessly integrates, curates, and animates scientific trial knowledge, delivering extra actionable insights for quicker determination making.
iCore is an revolutionary informatics platform which delivers novel insights and accelerates the drug improvement course of for precision medication.
About Saama Technologies, Inc.
Saama is the #1 AI scientific analytics platform firm, enabling the life sciences trade to conduct quicker and safer scientific improvement and regulatory packages. Today, over 50 biotech firms use Saama’s award-winning Life Science Analytics Cloud (LSAC) platform on greater than 1,500 research, together with most of the prime 20 pharmaceutical firms. LSAC’s wealthy purposes facilitate an unprecedented, authoritative oversight of complete scientific analysis knowledge, enabling firms to file New Drug Applications (NDAs) extra effectively and convey medicine to market quicker. Discover extra at www.saama.com and observe Saama @SaamaTechInc.
About iNDX Technology, Inc.
iNDX.Ai is a Silicon Valley-based knowledge analytics firm that has developed iCore, an revolutionary informatics platform that delivers novel insights and accelerates the drug improvement course of for precision medication. We are a extremely motivated staff of entrepreneurs, medical doctors, engineers, and knowledge scientists with a mission to develop revolutionary software program merchandise that may assist our collaborators discover a treatment for ailments like most cancers and COVID-19 and make a worldwide societal impression. The genomics revolution has created an information tsunami. We have developed a novel method for managing immuno-oncology scientific trials and translational analysis. Our choices allow customers to mixture, analyze, visualize, interrogate & correlate biomedical knowledge and collect strategic and predictive insights. For extra data go to http://www.indx.ai/.
View supply model on businesswire.com: https://www.businesswire.com/news/home/20200505005380/en/
Gregory T. Simpson